Aldose reductase inhibitors in the treatment of diabetic neuropathy : a review of the rationale and clinical evidenceMASSON, E. A; BOULTON, A. J. M.Drugs (Basel). 1990, Vol 39, Num 2, pp 190-202, issn 0012-6667Article

Impaired induction of nerve ornithine decarboxylase activity in the streptozotocin-diabetic rat is prevented by the aldose reductase inhibitor ponalrestatPEKINER, C; MCLEAN, W. G.British journal of pharmacology. 1990, Vol 101, Num 4, pp 978-980, issn 0007-1188, 3 p.Article